Date: February 20, 2024
Start Time: 9:00 am
End Time: 10:00 am
On February 20, 2024, ICAP presented the February Grand Rounds – Ending the STI Epidemic Through Prevention.
Every day, more than one million sexually transmitted infections (STIs) are acquired worldwide. Not only can STIs increase the risk of HIV, but they can also affect sexual and reproductive health through stigmatization, infertility, cancers, and pregnancy complications. During this Grand Rounds, two experts presented on different STI prevention approaches, including post-exposure prophylaxis (Doxy-PEP) and STI point-of-care diagnosis, for global vulnerable populations.
Jason Zucker is an assistant professor of Medicine in the Division of Infectious Diseases at Columbia University Medical Center and assistant medical director of the New York City STD Prevention Training Center. His research work is at the intersection of data science, behavioral science, and implementation science, focusing on optimizing engagement in the sexual health cascade of care. Jason trained as a combined adult and pediatric infectious diseases physician and is an experienced HIV, HIV prevention, and sexual health care provider. He provides status-neutral care to patients of all ages in the NewYork Presbyterian-Columbia Comprehensive Health Program Sexual Health Clinic.
Harriet Nuwagaba-Biribonwoha is a medical doctor and assistant professor of Epidemiology at Columbia University’s Mailman School of Public Health. She is the research director at ICAP in Eswatini where she oversees a diverse portfolio of clinical research, program evaluations, implementation science, surveys, and surveillance activities, and is the clinical research site leader at the Eswatini Prevention Center Clinical Research Site. She has led two Eswatini Population-based HIV Impact Assessments in 2016 and 2020, as well as the 2022 Eswatini Violence Against Children Survey. As a principal investigator, she has led important studies related to HIV prevention, including on oral and injectable PrEP, as well as COVID-19 and HPV vaccination among people living with HIV, and diagnosis and management of sexually transmitted infections.